Metastatic Melanoma Clinical Trials in Lexington, Kentucky

3 studies are recruiting for metastatic melanoma in Lexington, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

    This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transpl…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Kentucky/Markey Cancer Center, Lexington, Kentucky
    Locations
    26 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05896839 on ClinicalTrials.gov

  2. MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

    In this first-in human, phase I/IIa study, the safety and efficacy of [212Pb]VMT01, an alpha-particle emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluated as a monotherapy and in combination with nivolumab in subjects with unresectable and metastatic mel…

    Stage
    Phase 1
    Ages
    18 to 90
    Site
    University of Kentucky, Lexington, Kentucky
    Locations
    13 in total
    Run by
    Perspective Therapeutics

    See if you can join NCT05655312 on ClinicalTrials.gov

  3. Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

    This is a phase 1 dose-escalation study of nilotinib in combination with fixed-dose dabrafenib and trametinib regimen for patients with metastatic or unresectable melanoma carrying a BRAF V600 mutation and have relapsed on a BRAF/MEK inhibitor therapy. The goal is to assess the toxicity and tolerab…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Markey Cancer Center, Lexington, Kentucky
    Locations
    4 in total
    Run by
    Rina Plattner

    See if you can join NCT04903119 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.